| Mr Robert D Oliver, MD | |
|
226 Se Debell Ave, Bartlesville, OK 74006 | |
| (918) 333-4020 | |
| (918) 331-0213 |
| Full Name | Mr Robert D Oliver |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 226 Se Debell Ave, Bartlesville, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770686339 | NPI | - | NPPES |
| 100002330A | Medicaid | KS | |
| 100134030A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 10055 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert D Oliver, MD 226 Se Debell Ave, Bartlesville, OK 74006 Ph: (918) 333-4020 | Mr Robert D Oliver, MD 226 Se Debell Ave, Bartlesville, OK 74006 Ph: (918) 333-4020 |
News Archive
Aurora Breast MRI of Sarasota today announced it has partnered with Clear Channel Radio for a fundraising effort to benefit The Wellness Community of Southwest Florida. The fundraiser, titled "Change for Change," will consist of a series of breast cancer awareness messages throughout the month of October to encourage donations at area "Change for Change" locations.
ADP, a leading provider of human resources, payroll and benefits administration services, today announced that the University of Miami Hospital, the flagship hospital of UHealth – University of Miami Health System, has selected an integrated, outsourced solution from ADP to more efficiently manage the majority of its critical human capital management needs.
Viamet Pharmaceuticals, Inc. announced today that it has entered into a licensing option agreement with the Novartis Option Fund. Under terms of the agreement, Viamet will utilize its proprietary Metallophile™ Technology to discover and develop novel metalloenzyme inhibitors against a specific metalloenzyme of high interest to Novartis. The agreement includes an upfront fee and potential milestones totaling over $200 million as well as product royalties.
Shire plc, the global specialty biopharmaceutical company, today announced positive top-line results from a Phase 2 study to evaluate the safety and efficacy of Vyvanse (lisdexamfetamine dimesylate) Capsules, (CII) in adults with binge eating disorder.
› Verified 5 days ago
Dr. Aldon Elisworth Corle Jr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3400 E Frank Phillips Blvd, Bartlesville, OK 74006 Phone: 918-331-2533 Fax: 918-331-2539 | |
Dr. Tarynn Freeman, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3400 E Frank Phillips Blvd Ste 400, Bartlesville, OK 74006 Phone: 918-331-2533 |